3T Biosciences
Blood & Organ Banks · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
201 Haskins Way Fl 5, South San Francisc...Website
www.3tbiosciences.comRevenue
$8 MillionIndustry
ZI Rank: 3
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
3
3
4
2
3
About 3T Biosciences
3T Biosciences is an immunotherapy company focused on developing next-generation therapies for the treatment of solid tumors and other immune-mediated diseases. They aim to address a significant challenge in targeted biotherapeutics by identifying novel targets for cancer treatment. Their innovative approach positions them at the forefront of transforming cancer care for broad patient populations. The company is dedicated to advancing immunotherapy as a key component in the future of cancer treatment.Explore more
3T Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is 3T Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at 3T Biosciences
Click to see if 3T Biosciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on 3T Biosciences recently announced quarterly report
Funding: Get notified immidiatlly once 3T Biosciences has new funding data
Product Launch: Get notified when 3T Biosciences launches new products
Check out if 3T Biosciences is spiking on competitors!
3T Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if 3T Biosciences has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined 3T Biosciences as Masked Content
Find more new buyers
Compare Similar Companies to 3T Biosciences
Compare insights from companies similar to 3T Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$123.9M
51-200
Public
$462.1M
1994
TC
Tracy ClementeChief People Officer & Chief Human Resources Officer
Company Profile Activity
Activity Insights
3T Biosciences is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
3T Biosciences is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about 3T Biosciences.
3T Biosciences financials insights
Gather financial insights about 3T Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2022
Series A
$40M
3T Biosciences Tech Stack
A closer look at the technologies used by 3T Biosciences
Most Recent Scoops
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Promotion
Executive Move
Executive Moves, Promotion
Executive Move
Executive Moves, Board of Directors
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
3T Biosciences News & Media
3T Biosciences Builds Transatlantic Pan-Cancer Research Pipeline to Target Most Difficult-to-Treat Cancers
Collaborations with decorated academic investigators at Oxford University, VIB, KU Leuven, and University of California, San Francisco Research partnerships to identify novel targets in pancreatic, bladder, breast, head and neck, and colorectal cancers using 3T's best-in-class 3T-TRACE...Boehringer Ingelheim and 3T Biosciences enter into a second partnership to develop next-generation cancer immunotherapies
INGELHEIM, Germany and SOUTH SAN FRANCISCO, Calif., Jan. 4, 2024 /PRNewswire/ -- Boehringer Ingelheim and 3T Biosciences ("3T") today announced they have entered into a new strategic collaboration and licensing agreement focused on discovering and developing next-generation life-changing...3T Biosciences Expands Leadership Team With Bryan Irving, Ph.D., as Chief Scientific Officer to Progress Tumor-specific Therapies to Clinic
Highly respected T-cell immunologist brings more than three decades' experience working across diverse R&D disciplines in T-cell immunology and cancer biology Joining forces is Estelle Marrer-Berger, Ph.D., as chief development officer SOUTH SAN FRANCISCO, Calif., Oct. 25, 2023...Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
INGELHEIM, Germany and SOUTH SAN FRANCISCO, Calif., Jan. 9, 2023 /PRNewswire/ -- Boehringer Ingelheim and 3T Biosciences, today announced they have entered into a strategic collaboration and licensing agreement to discover and develop next-generation cancer therapies to address high unmet...
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding 3T Biosciences
Sign Up For FreeTo access detailed company insights
3T Biosciences is an immunotherapy company focused on developing next-generation therapies for the treatment of solid tumors and other immune-mediated diseases. They aim to address a significant challenge in targeted biotherapeutics by identifying novel targets for cancer treatment. Their innovative approach positions them at the forefront of trans... Read More
